title: [Primary renal angiosarcoma. Uncommon manifestation of a rare malignancy].
abstract: This article reports a case of primary renal angiosarcoma, a very rare and aggressive malignancy, in a 59-year-old male patient. The mean overall survival time is limited to a few months if the diagnosis is made when clinical symptoms are present but chances of a cure can be increased with surgical resection of smaller incidental findings. Due to the lack of a standard therapy, systemic treatment is based on the therapy of other soft tissue sarcomas. The role of adjuvant medical treatment particularly in angiosarcoma remains poorly studied but using a doxorubicin-based chemotherapy regimen, a survival benefit can be achieved.
authors: Klinik für Urologie und Neurourologie, Marien Hospital Herne, Ruhr-Universität Bochum, Widumer Str. 8, 44627, Herne, Deutschland, johannes.rueb@marienhospital-herne.de.
authors: J
authors: J
authors: Rüb
authors: S
authors: S
authors: Bauer
authors: J
authors: J
authors: Pastor
authors: J
authors: J
authors: Noldus
authors: R J
authors: RJ
authors: Palisaar
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D004317:Doxorubicin / Q000627:therapeutic use; D006394:Hemangiosarcoma / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000379:methods; D035583:Rare Diseases / Q000473:pathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin